Concepedia

Prabhakar Risbood

PR

Statistics

Publications

15

Citations

543

H-Index

13

Active since

1979

Affiliations

National Cancer Institute(Current)

Starks Associates

Frederick National Laboratory for Cancer Research

National Institutes of Health

University of Rhode Island

Prabhakar Risbood is an author at National Cancer Institute specializing in chemistry, natural sciences, and biochemistry.

ORCID

Publications per year

1979–2023

15

Publications

15

The synthesis of XTT: A new tetrazolium reagent that is bioreducible to a water‐soluble formazan

Kenneth D. Paull, Robert H. Shoemaker, Michael R. Boyd et al. · Journal of Heterocyclic Chemistry · 1988 · 151 citations

, , +4

Anticancer Specificity of Some Ellipticinium Salts against Human Brain Tumors in vitro

Edward M. Acton, V. L. Narayanan, Prabhakar Risbood et al. · Journal of Medicinal Chemistry · 1994 · 125 citations

, , +10

Catalytic deacylation of sugars with strong base ion-exchange resins; an alternative to the Zemplén procedure

Lawrence A. Reed, Prabhakar Risbood, Leon Goodman · Journal of the Chemical Society Chemical Communications · 1981 · 32 citations

, , +9

Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonists

Jun Wei, Michele F. Rega, Shinichi Kitada et al. · Cancer Letters · 2008 · 32 citations · Full text

, , +7

Characterization of potent and selective iodonium-class inhibitors of NADPH oxidases

Jiamo Lu, Prabhakar Risbood, Charles T. Kane et al. · Biochemical Pharmacology · 2017 · 32 citations · Full text

, , +13

1–5 of 15